NeoGenomics to acquire Genoptix in near $140M deal by Conor Hale Friday, October 26, 2018 NeoGenomics has moved to acquire clinical oncology laboratory Genoptix for $125 million in cash plus 1 million shares of stock.
PPD, NeoGenomics to integrate lab testing for cancer trials by Conor Hale Friday, June 1, 2018 PPD and NeoGenomics plan to integrate their pathology and molecular testing services, with a focus on clinical trials in oncology.
